EVs obtained from the standard chemotherapy treatment group presented an increase in several growth factors content, all related to colon cancer, while lower levels of VEGFR1 labeled EVs, as well as a significant reduction (>50%) in EVs growth factors content during and at the end of chemotherapy were found in the CC-W group. The gene discussed is FLT1; the disease is malignant colon neoplasm.